WO2003037423A1 - Method and apparatus for endovenous pacing lead - Google Patents
Method and apparatus for endovenous pacing lead Download PDFInfo
- Publication number
- WO2003037423A1 WO2003037423A1 PCT/US2002/031982 US0231982W WO03037423A1 WO 2003037423 A1 WO2003037423 A1 WO 2003037423A1 US 0231982 W US0231982 W US 0231982W WO 03037423 A1 WO03037423 A1 WO 03037423A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lead
- distal end
- cardiac vein
- electrical lead
- medical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N1/0565—Electrode heads
- A61N1/0568—Electrode heads with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M2025/0177—Introducing, guiding, advancing, emplacing or holding catheters having external means for receiving guide wires, wires or stiffening members, e.g. loops, clamps or lateral tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N2001/0585—Coronary sinus electrodes
Definitions
- This invention relates generally to a method and apparatus for electrically stimulating a heart, and, more particularly, to a method and apparatus for positioning and fixating an electrode lead to stimulate and/or sense activity in the heart.
- implantable medical devices include therapeutic and diagnostic devices, such as pacemakers, cardioverters, defibrillators, neural stimulators, drug administering devices, among others for alleviating the adverse effects of various health ailments.
- Today's implantable medical devices are also vastly more sophisticated and complex than their predecessors, and are therefore capable of performing considerably more complex tasks for reducing the effects of these health ailments.
- IMD implantable medical devices
- implantable cardioverter-defibrillators are used to treat patients suffering from ventricular fibrillation, a chaotic heart rhythm that can quickly result in death if not corrected.
- the ICD continuously monitors the electrical activity of a patient's heart, detects ventricular fibrillation, and in response to that detection, delivers appropriate shocks to restore normal heart rhythm.
- an automatic implantable defibrillator (AID) is available for therapeutic stimulation of the heart.
- an AID device detects ventricular fibrillation and delivers a non-synchronous high- voltage pulse to the heart through widely spaced electrodes located outside of the heart, thus mimicking transthoratic defibrillation.
- PCD pacemaker/cardioverter/defibrillator
- This device detects the onset of tachyarrhythmia and includes means to monitor or detect progression of the tachyarrhythmia so that progressively greater energy levels may be applied to the heart to interrupt a ventricular tachycardia or fibrillation.
- a programmable pacemaker for example a programmable pacemaker.
- each of the above-described IMDs generally comprise three primary components: a low-power control circuit, a high-power output circuit, and a power source.
- the control circuit monitors and determines various operating characteristics, such as, for example, rate, synchronization, pulse width and output voltage of heart stimulating pulses, as well as diagnostic functions such as monitoring the heart.
- the high-power output circuit generates electrical stimulating pulses to be applied to the heart via one or more leads in response to signals from the control circuit.
- the power source “powers" both the low-power control circuit and the high-power output circuit.
- the power source is typically required to provide 10-20 microamps to the control circuit and a high power pulse to the output circuit.
- the high-power output circuit may require a stimulation energy of as little as 0.1 Joules for pacemakers to as much as 40 Joules for implantable defibrillators.
- the power source must possess a low self-discharge to have a useful life of many years, must be highly reliable, and must be able to supply energy from a minimum packaged volume.
- Modern electrical therapeutic and diagnostic devices for the heart require a reliable electrical connection between the device and a particular region of the heart.
- transvenous leads are positioned through the venous system to attach or electrically connect at their distal end to the heart. At their proximal end, they are typically connected to the electrical therapeutic and diagnostic device, which may be implanted. Such leads normally take the form of a long, generally straight, flexible, insulated conductor.
- transvenous leads permit an electrical contact with the heart without physically exposing the heart itself, i.e., major thoracic surgery is not required.
- the specific design of transvenous leads is varied, depending upon the region of the heart to which it is to be connected. For example, U.S. Pat.
- No. 6,070,104 discloses an implantable lead capable of stimulating and/or sensing multiple chambers of the heart. Multiple electrodes are located on the lead and spaced apart so that multiple chambers may be separately stimulated and/or sensed.
- the structure and size of patients' hearts varies considerably. Accordingly, the optimal locations for positioning the electrodes within a vein may vary substantially, depending on the anatomy of the patient.
- the left ventricle is a portion of the heart that can be difficult in which to locate a lead due to the specific anatomical structure of the heart.
- One type of implantable lead that is used for positioning adjacent to the left ventricle is an endovenous epicardial lead.
- a typical left ventricular endovenous epicardial lead is one that is initially routed in the typical manner into the right atrium of the heart.
- the lead From the right atrium the lead is guided through the coronary sinus and into a cardiac vein that is attached to the left side of the heart. The lead is then inserted into the cardiac vein and extended in an attempt to reach a desired distal location adjacent to the left ventricle of the heart. This procedure is difficult due to the tortuous path that the lead is subjected to and due to the reduced diameter of the cardiac veins in the more distal locations. Another factor that complicates the left ventricular procedure is that the leads are limited in active fixation mechanisms. Right ventricular leads can utilize fixation mechanisms such as tines and screw-in lead tips. These fixation methods may be difficult for use with left ventricular leads due to the specific anatomical structure of the left sided endovenous system. There is a need for improved methods and apparatus for more efficient placement and fixation of endovenous epicardial left ventricular pacing leads within a heart.
- an apparatus for positioning a medical electrical lead in a heart.
- the medical electrical lead comprises an electrode coupled adjacent a distal end portion of the medical electrical lead, the distal end portion of the lead capable of insertion into the coronary sinus of a patient.
- a distribution device is attached to the distal end of the lead and adapted for dissipation of a material into the coronary sinus and into a cardiac vein.
- the material can comprise a vasodilating agent.
- a medical catheter device comprising a flexible tubular body having a distal end and a proximal end is disclosed.
- a first lumen is disposed within the flexible tubular body and is capable of transporting an electrical lead through the first lumen and out the distal end of the flexible tubular body.
- a method for positioning a medical electrical lead in a cardiac vein comprises inserting a lead within a portion of a patient's body, dispersing at least one vasodilating agent to dilate at least one vessel, and inserting the lead into a dilated vessel.
- Figure 1 schematically illustrates a prior art embodiment of an implanted medical device with an associated lead positioned within the right ventricle of a heart
- Figure 2 schematically illustrates a prior art embodiment of an implanted medical device with an endovenous epicardial lead positioned adjacent the left ventricle of a heart
- FIG. 3 is a perspective view of a guide catheter constructed in accordance with the principles of the present invention.
- Figure 4 illustrates an alternative distal end of the guide catheter of Figure 3, designed specifically for introduction to the coronary sinus;
- FIG. 5A schematically illustrates an alternate embodiment guide catheter constructed in accordance with the principles of the present invention
- FIG. 5B schematically illustrates the alternate embodiment guide catheter shown in
- FIG. 5A dispersing vasodilating agents into a cardiac vein in accordance with the principles of the present invention
- FIG. 6 schematically illustrates an alternate embodiment guide catheter constructed in accordance with the principles of the present invention
- Figure 7 schematically illustrates an alternate embodiment guide catheter constructed in accordance with the principles of the present invention
- Figure 8 schematically illustrates an alternate embodiment guide catheter constructed in accordance with the principles of the present invention
- Figure 9 shows cross-sectional views of one embodiment of the invention
- Figure 10 illustrates cross-sectional views of one particular embodiment of the invention.
- Embodiments of the present invention concern an electrical lead that may be implanted and used to stimulate and/or sense the atrium and ventricle of the left side of the heart through the coronary sinus.
- a typical coronary sinus is 10 millimeters at its largest diameter (near the outflow to the right atrium) and narrows until it has a diameter of between approximately 2-3 millimeters and merges to the great cardiac vein.
- any leads having larger sizes could be expected to diminish the flow of blood through the coronary sinus.
- the fixation of a lead within the coronary sinus or cardiac vein is further complicated by the fact that, unlike a heart chamber where the fibrotic tissue response is used to assist lead fixation, no such fibrotic response can be expected in the vein. As such no fibrotic tissue response is available to assist in lead fixation.
- embodiments of the present invention comprise a lead implantation apparatus and method that includes the dispensing of a vasodilating agent that induces a temporary dilating of the venous vessels during positioning of the lead.
- the vasodilating agent generally relaxes the cardiac vein, thereby making it easier to insert the cardiac lead into more distal locations.
- the cardiac vein will contract to its original size, thus fixating the cardiac lead by the contraction produced by the vascular musculature. This fixation can enable an increased lead stability and thereby an increased performance of the lead.
- FIG 1 illustrates a prior art implantable medical device (IMD) system 10, which includes an implantable electronic device 12, such as a pacemaker, defibrillator, or the like, that has been implanted in a patient.
- the device 12 is housed within a hermetically sealed, biologically inert outer canister or housing, which may itself be conductive so as to serve as an electrode in the pacemaker's pacing/sensing circuit.
- One or more pacemaker leads, collectively identified with reference numeral 14 in Figure 1 are electrically coupled to the pacemaker 12 in a conventional manner and extend into the patient's heart 16 via a vein, typically the superior vena cava vein 18.
- Disposed generally near a distal end 20 of the leads 14 are one or more exposed conductive electrodes for sensing cardiac activity, delivering electrical pacing stimuli to the heart 16, or providing a stimulating voltage to defibrillate the heart 16.
- the leads 14 may be implanted with their distal end situated adjacent the right atrium 22 or the right ventricle 24, or both, of the heart 16.
- the illustration of Figure 1 shows the distal end 20 of the lead 14 disposed within the right ventricle 24 of the heart 16. Due to the anatomical structure of the heart 16, it is more difficult to position a lead 14 within or adjacent to the left atrium 26 or left ventricle 28.
- the septum 30 is a wall that separates the right cavities 22, 24 from the left cavities 26, 28 of the heart 16 and prevents direct fluid communication between them.
- the septum 30 likewise presents a barrier to direct insertion of the lead 14 into either of the left cavities 26, 28 using the typical pathway of the superior vena cava 18.
- An alternate path to a location adjacent the left cavities 26, 28 is through the coronary sinus 32 that provides a passageway for oxygen depleted blood from the left side of the heart 16 to enter the right atrium 22.
- Figure 2 schematically illustrates a prior art embodiment of an implanted medical device with an endovenous epicardial lead 14 passing through the superior vena cava 18, through the right atrium 22, entering the coronary sinus 32 and its distal end 20 positioned within a cardiac vein 34 adjacent to the left ventricle 28 of a heart 16.
- the ability to position a lead 14 within this section of the heart 16 enables the implantable medical device (IMD) system 10 to provide left ventricle 28 and atrial 26 pacing, coronary sinus 32 defibrillation, left ventricle 28 defibrillation, other delivery of therapy and/or other form of sensing.
- IMD implantable medical device
- an exemplary guide catheter 40 includes a flexible tubular body 42 having a distal end 44 and a proximal end 46.
- a distributor 48 is mounted on the distal end 44 of the flexible tubular body 42, and a hub 50 is mounted on the proximal end 46 of the flexible tubular body 42.
- the axial lumen 52 of the tubular body 42 provides a passageway for a lead (e.g., an electrical lead) to be directed out of the distal end 44 of the catheter 40.
- a secondary connector 54 is connected to the tubular body 42 and to a secondary passageway or lumen 56 that is connected to the distributor 48.
- the secondary connector 54, second lumen 56, and the distributor 48 provide a means for transporting a material from the proximal end 46 to the distal end 44 of the catheter 40.
- the distributor 48 is mounted on the distal end 44 of the flexible tubular body 42, and a hub 50 is mounted on the proximal end 46 of the flexible tubular body 42.
- the material can comprise a vasodilating agent that promotes the dilation of the one or more vessels which the vasodilating agent contacts.
- vasodilating agents that can be used include Papaverin and Moxaverin.
- the dispensing of the vasodilating agent induces a temporary dilating of the venous vessels, relaxing the cardiac veins, thereby making it easier to place a cardiac lead through the axial lumen 52 of the catheter 40 and into more distal locations in the vessel, such as a cardiac vein. After placement of the lead within the vessel, the catheter 40 can be removed, while leaving the lead implanted within the vessel.
- the vessel will generally contract to its original size, thus assisting the fixation of the lead within the vessel.
- the vasodilating agent can assist in the placement of the lead into more distal locations within the heart and can assist in the fixation of the lead within the vessel once placed.
- This fixation can provide increased lead stability and thereby an increased performance of the lead.
- the secondary connector 54 can connect directly to the axial lumen 52 rather than a separate passageway 56 as shown.
- Vasodilating agents can be injected through the secondary connector 54, through the axial lumen 52 and to the distal end 44 of the catheter 40 for distribution either through the distributor 48 or out the end of the catheter 40.
- Figure 4 illustrates an alternate distal end 44 of the tubular body 42 of the catheter 40 embodiment shown in Figure 3. This illustration is configured for introduction of the distal end 44 of the tubular body 42 into the coronary sinus.
- an exemplary guide catheter 60 is shown inserted into the superior vena cava 18, passing through the right atrium 22 and passing into the coronary sinus 32.
- the guide catheter 60 comprises a flexible tubular body 62 having a distal end 64 and a proximal end 66.
- a distributor 68 At the distal end 64 of the tubular body 62 is a distributor 68, which is shown within the guide catheter 60.
- An alternate passageway 70 provides a path from the proximal end 66 of the catheter 60 to the distributor 68 at the distal end 64 of the tubular body 62.
- Figure 5B shows the guide catheter 60 inserted through the coronary sinus 32 to the cardiac veins 34.
- a vasodilating agent 72 is shown dispensed from the distributor 68 at the distal end 64 of the catheter 60.
- an injector element In response to pressure applied by an injector element
- the vasodilating agent 72 is forced through the alternate passageway 70 and is dispersed from the distributor 68 into one or more of the cardiac veins 34, promoting dilation of the cardiac veins 34.
- the guide catheter 60 may be possible to insert the guide catheter 60 further into one of the cardiac veins 34, where a lead can be disposed into a more distal location within the cardiac vein than would be possible without the dilating effects promoted by the vasodilating agent 72.
- FIG. 6 presents an alternate embodiment of a catheter device 40a having a flexible tubular body 42 and a distribution device 48 located approximate the distal end 44 of the device 40a.
- a secondary passageway 56 connects to the distribution device 48 and enables vasodilating agents to be transported to the distribution device 48.
- the distribution device 48 may comprise a porous material that dissipates the vasodilating agents in a substantially controlled manner.
- the distribution device 48 can typically dispense the vasodilating agents in a more uniform pattern than dispensing without the use of a distribution device 48.
- Figure 7 presents an alternate embodiment of a catheter device 40b having a flexible tubular body 42 and a distribution device 48 located approximate the distal end 44 of the device 40b.
- the distribution device 48 can be impregnated with the vasodilating agents prior to the catheter device 40b being inserted into the patient.
- the design parameters of the distribution device 48 material such as porosity of the material and the relative surface tensions of the distribution device 48 material and the vasodilating agents, will determine the rate of dissipation of the vasodilating agents from the distribution device 48.
- the distribution device 48 can comprise a sponge-like substance that can be saturated or impregnated by the vasodilating agents. Vasodilators can also be applied by chemically binding to or modifying the distribution device 48 material. Cardiac pacing leads can also be inserted and placed within a patient without the use of a catheter device. In these cases the vasodilator agents can be applied through the cardiac pacing lead itself. Cardiac pacing leads can comprise an elongated flexible body. The body of the lead can have a tubular shape and can be constructed of polyurethane or other similar material used within the medical industry for use inside the human body. The lead can comprise a core of electrically conductive material that is surrounded by a layer of insulative material. The lead will typically include an electrode that is coupled to or adjacent to the distal end of the lead. The lead can include an expandable helical coil coupled to its distal end.
- Figure 8 presents an alternate embodiment of the invention comprising an electrical lead device 40c having an elongated flexible tubular body 42 and a distal end 44.
- the tubular body 42 comprises a first section 74 and a more distal second section 76 that has a smaller diameter than the first section 74.
- the lead 40c can be tapered along a longitudinal axis of the elongated flexible body 42. The tapered shape can assist in the placement of the lead 40c to more distal locations within a vessel, such as a cardiac vein.
- the first section 74 has distribution apertures 75 and the second section 76 has distribution apertures 77, both capable of dispersing a vasodilating agent.
- the particular embodiment shows protrusions 78 from the distal end 44 of the lead 40c.
- the protrusions 78 can assist in providing electrical contact between the lead 40c and the cardiac vein and can assist in the fixation mechanism of the lead 40c to the heart.
- Anchoring means attached to the distal end 44 of the lead 40c can assist the fixation of the lead within a cardiac vein. Examples of anchoring means include projections, expanding helical coils and ribs on the exterior surface of the lead. These can all assist with the contraction of the vein in providing a fixation of the lead within the cardiac vein.
- a guide wire is used to initiate the insertion into a particular location within the heart, such as a cardiac vein.
- the guide wire can be used in conjunction with the lead, such as having the guide wire proceed through a axial lumen within the lead, whereby after the placement of the lead the guide wire can be removed from the lumen, leaving the lead implanted within the patient.
- These leads are commonly referred to as an "over-the- wire" type of implantable electrical lead.
- Figure 9 shows cross-sectional views of one embodiment of the invention comprising a pacing lead 80a having a first lumen 82 and a second lumen 84.
- the first lumen 82 is used to house a guide wire 86 while the second lumen 84 provides a passageway to the distal end 88 of the lead 80a.
- the second lumen 84 can be used to transport and dispense vasodilating agents to the distal end 88 of the lead 80 and can comprise a plurality of outlets 90 to dissipate the vasodilating agents.
- FIG. 10 illustrates cross-sectional views of one particular embodiment of the invention in which the vasodilating agents are transferred to the distal end of the lead through the annulus area between the guide wire and the lumen within the lead.
- Figure 10 comprises a pacing lead 80b having a first lumen 82 used to house a guide wire 86.
- An annulus area 92 between the first lumen 82 and the guide wire 86 can be used to transport and dispense vasodilating agents to the distal end 88 of the lead 80b and can comprise a plurality of outlets 94 along the length of the lead 80 to dissipate the vasodilating agents.
- catheter devices such as shown in
- the embodiment of the lead 80 shown in Figure 10 can further comprise a means of distribution to more evenly dissipate the vasodilating agent (e.g. a distribution device
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002460053A CA2460053A1 (en) | 2001-10-29 | 2002-10-07 | Method and apparatus for endovenous pacing lead |
EP02802432A EP1444005A1 (en) | 2001-10-29 | 2002-10-07 | Method and apparatus for endovenous pacing lead |
JP2003539762A JP2005507717A (en) | 2001-10-29 | 2002-10-07 | Method and apparatus for intravenous pacing leads |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/041,802 | 2001-10-29 | ||
US10/041,802 US6936040B2 (en) | 2001-10-29 | 2001-10-29 | Method and apparatus for endovenous pacing lead |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2003037423A1 true WO2003037423A1 (en) | 2003-05-08 |
WO2003037423B1 WO2003037423B1 (en) | 2003-12-04 |
WO2003037423A8 WO2003037423A8 (en) | 2004-03-25 |
Family
ID=21918390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/031982 WO2003037423A1 (en) | 2001-10-29 | 2002-10-07 | Method and apparatus for endovenous pacing lead |
Country Status (5)
Country | Link |
---|---|
US (3) | US6936040B2 (en) |
EP (1) | EP1444005A1 (en) |
JP (1) | JP2005507717A (en) |
CA (1) | CA2460053A1 (en) |
WO (1) | WO2003037423A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010019654A1 (en) * | 2008-08-12 | 2010-02-18 | Cardiac Pacemakers, Inc. | Implantable lead and coronary venous pressure sensor apparatus and method |
US8795319B2 (en) | 2011-03-02 | 2014-08-05 | Cook Medical Technologies Llc | Embolization coil |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPR148400A0 (en) * | 2000-11-14 | 2000-12-07 | Cochlear Limited | Apparatus for delivery of pharmaceuticals to the cochlea |
US9089450B2 (en) * | 2000-11-14 | 2015-07-28 | Cochlear Limited | Implantatable component having an accessible lumen and a drug release capsule for introduction into same |
US6936040B2 (en) * | 2001-10-29 | 2005-08-30 | Medtronic, Inc. | Method and apparatus for endovenous pacing lead |
AUPR879201A0 (en) * | 2001-11-09 | 2001-12-06 | Cochlear Limited | Subthreshold stimulation of a cochlea |
AT507045B1 (en) * | 2002-11-29 | 2010-04-15 | Cochlear Ltd | IMPLANTABLE, TISSUE-STIMULATING DEVICE |
US20050080472A1 (en) * | 2003-10-10 | 2005-04-14 | Atkinson Robert Emmett | Lead stabilization devices and methods |
WO2006090337A2 (en) * | 2005-02-25 | 2006-08-31 | Koninklijke Philips Electronics N.V. | Method and apparatus for synchronizing wireless receiver |
US10166066B2 (en) | 2007-03-13 | 2019-01-01 | University Of Virginia Patent Foundation | Epicardial ablation catheter and method of use |
US11058354B2 (en) | 2007-03-19 | 2021-07-13 | University Of Virginia Patent Foundation | Access needle with direct visualization and related methods |
EP2134253B1 (en) | 2007-03-19 | 2022-01-26 | University Of Virginia Patent Foundation | Access needle pressure sensor device |
US9468396B2 (en) | 2007-03-19 | 2016-10-18 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
US9211405B2 (en) | 2007-03-22 | 2015-12-15 | University Of Virginia Patent Foundation | Electrode catheter for ablation purposes and related method thereof |
US20100241185A1 (en) | 2007-11-09 | 2010-09-23 | University Of Virginia Patent Foundation | Steerable epicardial pacing catheter system placed via the subxiphoid process |
US9642534B2 (en) | 2009-09-11 | 2017-05-09 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
CA2790328C (en) | 2010-02-18 | 2017-04-18 | University Of Virginia Patent Foundation | System, method, and computer program product for simulating epicardial electrophysiology procedures |
US8617097B2 (en) | 2010-05-24 | 2013-12-31 | Cochlear Limited | Drug-delivery accessory for an implantable medical device |
JP2012161496A (en) * | 2011-02-08 | 2012-08-30 | Terumo Corp | Lead assembly, electrical stimulation device, and lead |
US9289593B1 (en) | 2011-10-11 | 2016-03-22 | A-Hamid Hakki | Endovascular electrode system for tissue stimulation |
US9775991B1 (en) | 2011-10-11 | 2017-10-03 | A-Hamid Hakki | Endovascular electrode system for tissue stimulation with embedded generator |
US10500394B1 (en) | 2011-10-11 | 2019-12-10 | A-Hamid Hakki | Pacemaker system equipped with a flexible intercostal generator |
CN108348756B (en) | 2015-11-20 | 2021-10-22 | 心脏起搏器股份公司 | Single channel coronary vein lead for multi-chamber sensing and pacing |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4375817A (en) | 1979-07-19 | 1983-03-08 | Medtronic, Inc. | Implantable cardioverter |
US4819662A (en) * | 1987-10-26 | 1989-04-11 | Cardiac Pacemakers, Inc. | Cardiac electrode with drug delivery capabilities |
US5033998A (en) * | 1984-01-20 | 1991-07-23 | Eliot Corday | Retrograde delivery of pharmacologic and diagnostic agents via venous circulation |
EP0649637A1 (en) * | 1988-08-24 | 1995-04-26 | SLEPIAN, Marvin J. | Material for endoluminal paving and sealing |
US5571161A (en) * | 1995-04-12 | 1996-11-05 | Starksen; Niel F. | Apparatus and method for implanting electrical leads in the heart |
US5611775A (en) * | 1993-03-15 | 1997-03-18 | Advanced Cardiovascular Systems, Inc. | Method of delivery therapeutic or diagnostic liquid into tissue surrounding a body lumen |
EP0919254A2 (en) * | 1997-11-28 | 1999-06-02 | Medtronic, Inc. | Medical electrical lead |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4506680A (en) * | 1983-03-17 | 1985-03-26 | Medtronic, Inc. | Drug dispensing body implantable lead |
US5350395A (en) * | 1986-04-15 | 1994-09-27 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
JPS63158064A (en) * | 1986-12-23 | 1988-07-01 | テルモ株式会社 | Blood vessel dilating catheter |
US4946457A (en) * | 1987-12-03 | 1990-08-07 | Dimed, Incorporated | Defibrillator system with cardiac leads and method for transvenous implantation |
CA1327838C (en) * | 1988-06-13 | 1994-03-15 | Fred Zacouto | Implantable device to prevent blood clotting disorders |
US5234407A (en) * | 1991-03-06 | 1993-08-10 | Baxter International Inc. | Method and device for exchanging cardiovascular guide catheter while a previously inserted angioplasty guide wire remains in place |
US5523092A (en) * | 1993-04-14 | 1996-06-04 | Emory University | Device for local drug delivery and methods for using the same |
US5681278A (en) * | 1994-06-23 | 1997-10-28 | Cormedics Corp. | Coronary vasculature treatment method |
US5571085A (en) * | 1995-03-24 | 1996-11-05 | Electro-Catheter Corporation | Steerable open lumen catheter |
US5609629A (en) * | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
CA2223990C (en) * | 1995-06-07 | 2007-01-30 | Cardima, Inc. | Guiding catheter for coronary sinus |
US5755766A (en) * | 1997-01-24 | 1998-05-26 | Cardiac Pacemakers, Inc. | Open-ended intravenous cardiac lead |
US6086582A (en) * | 1997-03-13 | 2000-07-11 | Altman; Peter A. | Cardiac drug delivery system |
TW422712B (en) * | 1997-04-01 | 2001-02-21 | Wako Pure Chem Ind Ltd | Liquid test components separation method and equipment thereof |
US5916209A (en) * | 1997-12-24 | 1999-06-29 | Mick; Matthew J. | Coronary catheters for use in a transradial catheterization |
US6364856B1 (en) * | 1998-04-14 | 2002-04-02 | Boston Scientific Corporation | Medical device with sponge coating for controlled drug release |
US6408213B1 (en) * | 1999-09-29 | 2002-06-18 | Cardiac Pacemakers, Inc. | Low profile, ventricular, transvenous, epicardial defibrillation lead |
US6584362B1 (en) * | 2000-08-30 | 2003-06-24 | Cardiac Pacemakers, Inc. | Leads for pacing and/or sensing the heart from within the coronary veins |
US6510348B2 (en) * | 2000-12-20 | 2003-01-21 | Medtronic, Inc. | Perfusion lead and method of use |
US6711443B2 (en) * | 2001-07-25 | 2004-03-23 | Oscor Inc. | Implantable coronary sinus lead and method of implant |
US6936040B2 (en) | 2001-10-29 | 2005-08-30 | Medtronic, Inc. | Method and apparatus for endovenous pacing lead |
US6889091B2 (en) * | 2002-03-06 | 2005-05-03 | Medtronic, Inc. | Method and apparatus for placing a coronary sinus/cardiac vein pacing lead using a multi-purpose side lumen |
-
2001
- 2001-10-29 US US10/041,802 patent/US6936040B2/en not_active Expired - Fee Related
-
2002
- 2002-10-07 JP JP2003539762A patent/JP2005507717A/en active Pending
- 2002-10-07 EP EP02802432A patent/EP1444005A1/en not_active Withdrawn
- 2002-10-07 WO PCT/US2002/031982 patent/WO2003037423A1/en active Application Filing
- 2002-10-07 CA CA002460053A patent/CA2460053A1/en not_active Abandoned
-
2005
- 2005-04-06 US US11/099,773 patent/US20050177218A1/en not_active Abandoned
- 2005-07-25 US US11/189,053 patent/US7657323B2/en not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4375817A (en) | 1979-07-19 | 1983-03-08 | Medtronic, Inc. | Implantable cardioverter |
US5033998A (en) * | 1984-01-20 | 1991-07-23 | Eliot Corday | Retrograde delivery of pharmacologic and diagnostic agents via venous circulation |
US4819662A (en) * | 1987-10-26 | 1989-04-11 | Cardiac Pacemakers, Inc. | Cardiac electrode with drug delivery capabilities |
EP0649637A1 (en) * | 1988-08-24 | 1995-04-26 | SLEPIAN, Marvin J. | Material for endoluminal paving and sealing |
US5611775A (en) * | 1993-03-15 | 1997-03-18 | Advanced Cardiovascular Systems, Inc. | Method of delivery therapeutic or diagnostic liquid into tissue surrounding a body lumen |
US5571161A (en) * | 1995-04-12 | 1996-11-05 | Starksen; Niel F. | Apparatus and method for implanting electrical leads in the heart |
EP0919254A2 (en) * | 1997-11-28 | 1999-06-02 | Medtronic, Inc. | Medical electrical lead |
US6070104A (en) | 1997-11-28 | 2000-05-30 | Medtronic, Inc. | Medical electrical right atrium and coronary sinus lead |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010019654A1 (en) * | 2008-08-12 | 2010-02-18 | Cardiac Pacemakers, Inc. | Implantable lead and coronary venous pressure sensor apparatus and method |
US8340767B2 (en) | 2008-08-12 | 2012-12-25 | Cardiac Pacemakers, Inc. | Implantable lead and coronary venous pressure sensor apparatus and method |
US8594792B2 (en) | 2008-08-12 | 2013-11-26 | Cardiac Pacemakers, Inc. | Implantable lead and coronary venous pressure sensor apparatus and method |
AU2009282025B2 (en) * | 2008-08-12 | 2014-02-13 | Cardiac Pacemakers, Inc. | Implantable lead and coronary venous pressure sensor apparatus and method |
US8795319B2 (en) | 2011-03-02 | 2014-08-05 | Cook Medical Technologies Llc | Embolization coil |
Also Published As
Publication number | Publication date |
---|---|
US20030083725A1 (en) | 2003-05-01 |
WO2003037423B1 (en) | 2003-12-04 |
WO2003037423A8 (en) | 2004-03-25 |
EP1444005A1 (en) | 2004-08-11 |
CA2460053A1 (en) | 2003-05-08 |
US7657323B2 (en) | 2010-02-02 |
JP2005507717A (en) | 2005-03-24 |
US20050177218A1 (en) | 2005-08-11 |
US6936040B2 (en) | 2005-08-30 |
US20050256559A1 (en) | 2005-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7657323B2 (en) | Endovenous device for dispersing a dilating agent | |
US7386351B2 (en) | Method and apparatus for placing a coronary sinus/cardiac vein pacing and defibriliation lead with adjustable electrode spacing | |
US6141594A (en) | Single pass lead and system with active and passive fixation elements | |
US5423865A (en) | Electrode system for a defibrillator | |
US5954761A (en) | Implantable endocardial lead assembly having a stent | |
US5871531A (en) | Medical electrical lead having tapered spiral fixation | |
US5431683A (en) | Electrode system for a defibrillator | |
US7529592B2 (en) | Subcutaneous electrode and lead with temporary pharmacological agents | |
US7555351B2 (en) | Pulmonary artery lead for atrial therapy and atrial pacing and sensing | |
US6129750A (en) | Fixation mechanism for a coronary venous pacing lead | |
US5755764A (en) | Implantable cardiac stimulation catheter | |
US7628801B2 (en) | Coronary vein leads having an atraumatic tip and method therefor | |
US5755766A (en) | Open-ended intravenous cardiac lead | |
US20020045926A1 (en) | Implantable lead with dissolvable coating for improved fixation and extraction | |
US20090088827A1 (en) | Lead assembly providing sensing or stimulation of spaced-apart myocardial contact areas | |
US5964793A (en) | Lead introducer with defibrillation electrode and method of atrial defibrillation | |
EP1592479B1 (en) | Tachy lead system for septal placement | |
US7076309B2 (en) | Apparatus and method for fixedly engaging an electrical lead | |
US7010358B1 (en) | Single lead system for high voltage CHF device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
B | Later publication of amended claims |
Free format text: 20030403 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2460053 Country of ref document: CA |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 19/2003 UNDER (22) REPLACE "03 OCTOBER 2002 (03.10.2002)" BY "07 OCTOBER 2002 (07.10.2002)" |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003539762 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002802432 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002802432 Country of ref document: EP |